ClinicalTrials.Veeva

Menu

Research of Resistance to Antiplatelet Agents and Development of Tailored Treatment Model for Patients With Coronary Artery Disease

Y

Young-Hak Kim, MD, PhD

Status

Completed

Conditions

Coronary Artery Disease
Cardiovascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT02121054
2013-0873

Details and patient eligibility

About

The purpose of this study is to evaluate the prognosis of patients with resistance to antiplatelet agent and develop tailored treatment model for patients with coronary artery disease.

Enrollment

1,527 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >20
  • Patients with coronary artery disease
  • Patients with peripheral artery disease

Exclusion criteria

  • Renal dysfunction
  • Hepatic dysfunction
  • Major surgery planned within 1 year
  • Malignant tumor
  • History of gastrointestinal bleeding
  • low or high platelet count

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems